P10636 |
TAU_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P10636 |
TAU_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P10636 |
TAU_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P10636 |
TAU_HUMAN |
Choreiform disorder [ICD-11: 8A01] |
P10636 |
TAU_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P10636 |
TAU_HUMAN |
Central nervous system disease [ICD-11: 8A04-8D87] |
P10636 |
TAU_HUMAN |
Neurodegenerative disorder [ICD-11: 8A20-8A23] |
P11473 |
VDR_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
P11473 |
VDR_HUMAN |
Hair/hair growth developmental defect [ICD-11: LC30] |
P11473 |
VDR_HUMAN |
Hyper-parathyroidism [ICD-11: 5A51] |
P11473 |
VDR_HUMAN |
Hypo-parathyroidism [ICD-11: 5A50] |
P11473 |
VDR_HUMAN |
Mineral deficiency [ICD-11: 5B5K] |
P11473 |
VDR_HUMAN |
Psoriasis [ICD-11: EA90] |
P11473 |
VDR_HUMAN |
Vitamin deficiency [ICD-11: 5B55-5B5F] |
P11473 |
VDR_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
P11473 |
VDR_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P11473 |
VDR_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P11473 |
VDR_HUMAN |
Prostate disease [ICD-11: GA91] |
P11473 |
VDR_HUMAN |
Abnormal micturition [ICD-11: MF50] |
P11473 |
VDR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11473 |
VDR_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P11473 |
VDR_HUMAN |
Acne vulgaris [ICD-11: ED80] |
O95398 |
RPGF3_HUMAN |
Epidermal dysplasias [ICD-11: EK90] |
P53350 |
PLK1_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P53350 |
PLK1_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P53350 |
PLK1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P53350 |
PLK1_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P53350 |
PLK1_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P53350 |
PLK1_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P53350 |
PLK1_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P53350 |
PLK1_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
P53350 |
PLK1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q03431 |
PTH1R_HUMAN |
Low bone mass disorder [ICD-11: FB83] |
Q03431 |
PTH1R_HUMAN |
Hypo-parathyroidism [ICD-11: 5A50] |
Q14191 |
WRN_HUMAN |
Mature T-cell lymphoma [ICD-11: 2A90] |
Q13526 |
PIN1_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q13526 |
PIN1_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
Q96KQ7 |
EHMT2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q96KQ7 |
EHMT2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q96KQ7 |
EHMT2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P25779 |
CYSP_TRYCR |
Parasitic worm infestation [ICD-11: 1F90] |
P25779 |
CYSP_TRYCR |
Malaria [ICD-11: 1F40-1F45] |
P04054 |
PA21B_HUMAN |
Leishmaniasis [ICD-11: 1F54] |
P04054 |
PA21B_HUMAN |
Lichen planus [ICD-11: EA91] |
P04054 |
PA21B_HUMAN |
Peroxisomal disease [ICD-11: 5C57] |
P04054 |
PA21B_HUMAN |
Rosacea [ICD-11: ED90] |
P04054 |
PA21B_HUMAN |
Synthesis disorder [ICD-11: 5C52-5C59] |
P04054 |
PA21B_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P04054 |
PA21B_HUMAN |
Contact dermatitis [ICD-11: EK00-EK0Z] |
P04054 |
PA21B_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P04054 |
PA21B_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P04054 |
PA21B_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
P04054 |
PA21B_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P04054 |
PA21B_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P04054 |
PA21B_HUMAN |
Asthma [ICD-11: CA23] |
P04054 |
PA21B_HUMAN |
Pruritus [ICD-11: EC90] |
P04054 |
PA21B_HUMAN |
Unspecific body region injury [ICD-11: ND56] |
P04054 |
PA21B_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P04054 |
PA21B_HUMAN |
Leishmaniasis [ICD-11: 1F54] |
P04054 |
PA21B_HUMAN |
Lichen planus [ICD-11: EA91] |
P04054 |
PA21B_HUMAN |
Peroxisomal disease [ICD-11: 5C57] |
P04054 |
PA21B_HUMAN |
Rosacea [ICD-11: ED90] |
P04054 |
PA21B_HUMAN |
Synthesis disorder [ICD-11: 5C52-5C59] |
P04054 |
PA21B_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P04054 |
PA21B_HUMAN |
Contact dermatitis [ICD-11: EK00-EK0Z] |
P04054 |
PA21B_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P04054 |
PA21B_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P04054 |
PA21B_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
P04054 |
PA21B_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P04054 |
PA21B_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P04054 |
PA21B_HUMAN |
Asthma [ICD-11: CA23] |
P04054 |
PA21B_HUMAN |
Pruritus [ICD-11: EC90] |
P04054 |
PA21B_HUMAN |
Unspecific body region injury [ICD-11: ND56] |
P04054 |
PA21B_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P26358 |
DNMT1_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P26358 |
DNMT1_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P26358 |
DNMT1_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P26358 |
DNMT1_HUMAN |
Myeloproliferative neoplasm [ICD-11: 2A20] |
P26358 |
DNMT1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P26358 |
DNMT1_HUMAN |
Bladder cancer [ICD-11: 2C94] |
P26358 |
DNMT1_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P26358 |
DNMT1_HUMAN |
Lung cancer [ICD-11: 2C25] |
P26358 |
DNMT1_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P26358 |
DNMT1_HUMAN |
Brain cancer [ICD-11: 2A00] |
P26358 |
DNMT1_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P26358 |
DNMT1_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P26358 |
DNMT1_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P26358 |
DNMT1_HUMAN |
Myeloproliferative neoplasm [ICD-11: 2A20] |
P26358 |
DNMT1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P26358 |
DNMT1_HUMAN |
Bladder cancer [ICD-11: 2C94] |
P26358 |
DNMT1_HUMAN |
Kaposi sarcoma [ICD-11: 2B57] |
P26358 |
DNMT1_HUMAN |
Lung cancer [ICD-11: 2C25] |
P26358 |
DNMT1_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P26358 |
DNMT1_HUMAN |
Brain cancer [ICD-11: 2A00] |